<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_NTHU_Formosa_Nanobody skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:NTHU Formosa/Nanobody</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="wrap"><HEADER><DIV class="inner relative"><NAV id="navigation"><UL id="main-menu"><LI class="current-menu-item"><A href="https://2018.igem.org/Team:NTHU_Formosa#0">HOME</A></LI><LI class="parent"><A href="https://2018.igem.org/Team:NTHU_Formosa#1">Project</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Description"> Introduction</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Design">  Design</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Safety"> Biosafety</A></LI><LI><A class="parent" href="https://2018.igem.org/Team:NTHU_Formosa/Applied_Design"> Applied Design</A></LI></UL><LI class="parent"><A href="https://2018.igem.org/Team:NTHU_Formosa#2">Experiment</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Parts">Parts &amp; Component</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Composite_Part">Composite Part</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/InterLab">InterLab</A></LI><LI class="parent"><A href="https://2018.igem.org/Team:NTHU_Formosa/Model">Modeling</A></LI><LI class="parent"><A href="https://2018.igem.org/Team:NTHU_Formosa#4">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Public_Engagement">Public Engagement</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Human_Practices">Integrated Human Practices</A></LI><LI class="parent"><A href="https://2018.igem.org/Team:NTHU_Formosa#5">About us</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Team">Members</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Sponsor">Sponsors</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Attributions">Attributions</A></LI><LI><A href="https://igem.org/2018_Judging_Form?team=NTHU_Formosa">Judging Form</A></LI><LI><A href="https://2018.igem.org/Team:NTHU_Formosa/Medal">Medal</A></LI></NAV></DIV></HEADER></DIV><DIV class="w3-container w3-padding-64 w3-center"><DIV class="w3-content"><H2 class="w3-center" style="font-size:45px;font-family:Quicksand;"><B>Nanobody</B></H2><P class="w3-justify" style="font-size:22px;font-family:Quicksand;">
 　 Nanobodies are single variable domain antibody fragments (VHH) derived from heavy-chain only antibodies discovered and identified in at least two types of organisms, camelidae (e.g., camel and llama) and cartilaginous fish (e.g., nurse shark and Wobbegong).

      
 　 The molecular size of nanobody is about 3 nm (15kDa), 1/10000 of hair diameter. Such property earned it the name, nanobody. They are more hydrophilic than conventional antibodies. They withstand big pH variation. Their small size gives them the ability to penetrate the tissue faster and to reach deeper into the binding pockets of enzymes. Being able to refold after heat denaturation keeps nanobodies functional and active at 70°C or 2-hour 90°C heat shock.
      
 　 Nanobodies retain full antigen binding capacity and are considerably stable. Conventional antibodies are composed with variable domains along with heavy chains and light chains. When binding with proteins, all three parts of them are necessarily involved. Hence, nanobodies’ comparably simple structure greatly increases their antigen binding affinity. What’s even better is that it’s less costly to make nanobodies than antibodies. According to the information from iCAN database (<A href="http://ican.ils.seu.edu.cn">Institute collection and Analysis of Nanobody</A>),
        over two thousand nanobodies are available for recognizing different antigens including molecular-bound molecules and soluble molecules.
      
 　 Compared with antibodies, the unique features that nanobodies possess make them ideal for therapeutic and bioengineering tools. As a result, nanobodies are applied in our mechanism.</P><TABLE><TBODY><TR><TH><FONT face="Quicksand" size="3px">Name</FONT></TH><TH><FONT face="Quicksand" size="3px">Conventional antibody</FONT></TH><TH><FONT face="Quicksand" size="3px">Nanobody</FONT></TH></TR><TR><TD><FONT face="Quicksand" size="3px">Size</FONT></TD><TD><FONT face="Quicksand" size="3px">150–160 kDa</FONT></TD><TD><FONT face="Quicksand" size="3px">12-15 kDa</FONT></TD></TR><TR><TD><FONT face="Quicksand" size="3px">Composition</FONT></TD><TD><FONT face="Quicksand" size="3px">Variable domains + Heavy chains + Light chains</FONT></TD><TD><FONT face="Quicksand" size="3px">Variable domain fragments</FONT></TD></TR><TR><TD><FONT face="Quicksand" size="3px">Structure (incomparison)</FONT></TD><TD><FONT face="Quicksand" size="3px">Complex</FONT></TD><TD><FONT face="Quicksand" size="3px">Simple</FONT></TD></TR><TR><TD><FONT face="Quicksand" size="3px">Antigen binding affinity</FONT></TD><TD><FONT face="Quicksand" size="3px">High</FONT></TD><TD><FONT face="Quicksand" size="3px">Even better (nano-to-picomolar affinities)</FONT></TD></TR><TR><TD><FONT face="Quicksand" size="3px">Thermal Stability</FONT></TD><TD><FONT face="Quicksand" size="3px">65°C for 20 mins diminishes the activities of almost all antibodies</FONT></TD><TD><FONT face="Quicksand" size="3px">Highly heat-resistant (functional and active at 70°C or even at 2-hour 90°C heat shock)</FONT></TD></TR><TR><TD><FONT face="Quicksand" size="3px">Price</FONT></TD><TD><FONT face="Quicksand" size="3px">Varies with the products</FONT></TD><TD><FONT face="Quicksand" size="3px">Less expensive than antibodies</FONT></TD></TR></TBODY></TABLE></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>